The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000419.5:c.1429G>C

CA399803370

2506407 (ClinVar)

Gene: ITGA2B (HGNC:3674)
Condition: Glanzmann thrombasthenia (MONDO:0100326)
Inheritance Mode: Autosomal recessive inheritance
UUID: 9c5d7371-edaf-46f4-a59c-faad98839c61
Approved on: 2026-01-20
Published on: 2026-01-20

HGVS expressions

NM_000419.5:c.1429G>C
NC_000017.11:g.44380610C>G
CM000679.2:g.44380610C>G
NC_000017.10:g.42457978C>G
CM000679.1:g.42457978C>G
NC_000017.9:g.39813504C>G
NG_008331.1:g.13896G>C
ENST00000262407.6:c.1429G>C
ENST00000648408.1:c.860G>C
ENST00000262407.5:c.1429G>C
ENST00000592226.5:n.902G>C
ENST00000592462.5:n.224G>C
NM_000419.3:c.1429G>C
NM_000419.4:c.1429G>C
More

Likely Pathogenic

Met criteria codes 4
PM3_Supporting PS3_Moderate PP4_Moderate PM2_Supporting
Not Met criteria codes 1
PP3

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Platelet Disorders Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 2.1

PDF
Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Platelet Disorders VCEP
The NM_000419.5(ITGA2B):c.1429G>C (p.Ala477Pro) missense variant was detected in a patient with GT (PMID 15946231) with epistaxis, gingival bleeding, and purpura. This variant is absent from the gnomAD database v2.1.1 (PM2_Supporting). This variant was detected in the homozygous state in a patient with GT (PMID 15946231; PM3_supporting). Transfected CHO cells were used to measure the surface expression of normal and mutant αIIbβ3 receptors was performed using MoAb SZ22; only 14% expression was noted (PS3_Moderate). This variant was identified in a patient (PMID 15946231) with recurrent epistaxis, gingival hemorrhage, and purpura. They demonstrated a normal platelet count, prolonged bleeding time, and absence of platelet aggregation in response to adenosine diphosphate (ADP), epinephrine, and collagen; he had a normal response to ristocetin and decreased αIIbβ3 expression (PP4_Moderate). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive Glanzmann Thrombasthenia based on the ACMG/AMP criteria applied, as specified by the ClinGen PD VCEP: PP4_Moderate, PS3_Moderate, PM2_supporting, PM3_supporting.
Met criteria codes
PM3_Supporting
This variant was detected in the homozygous state in a patient with GT (PMID 15946231).
PS3_Moderate
Transfected CHO cells were used to measure the surface expression of normal and mutant αIIbβ3 receptors was performed using MoAb SZ22; only 14% expression was noted.

PP4_Moderate
This variant was identified in a patient (PMID 15946231) with recurrent epistaxis, gingival hemorrhage, and purpura. They demonstrated a a normal platelet count, prolonged bleeding time, and absence of platelet aggregation in response to adenosine diphosphate (ADP), epinephrine, and collagen; he had a normal response to ristocetin and decreased αIIbβ3 expression.
PM2_Supporting
This variant is absent from the gnomAD database v2.1.1 (PM2_Supporting).
Not Met criteria codes
PP3
This variant has a REVEL score of 0.576 that does not meet with threshold established by the PD VCEP of >/= 0.7 (PP3_NotMet).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.